Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.

Old Articles: <Older 9331-9340 Newer>

BusinessWeek September 5, 2005 Gene G. Marcial	Climbing: Alaska and AMR While Wall Street sees airlines as outcasts and heavily laden with risks, one analyst is upbeat about Alaska Air Group and AMR, parent of American Airlines, rating them "outperform."
BusinessWeek September 5, 2005 Louise Lee	What's Dogging Dell's Stock Worries over growth are holding down Dell's shares while those of rival Hewlett Packard take off.
BusinessWeek September 5, 2005 Gene G. Marcial	Tarragon Is Raising The Roof Homebuilder Tarragon's stock is up from 12 to 21.
BusinessWeek September 5, 2005 Gene G. Marcial	AtheroGenics May Be A Buyout AtheroGenics is one of the more attractive acquisition candidates of Merck or Pfizer.
The Motley Fool August 26, 2005 S.J. Caplan	Camera-Ready Results for WPP Bellwether London-based advertising agency WPP Group's first-half net profit soars. Investors, take note.
The Motley Fool August 26, 2005 Seth Jayson	Kodak, Fading Fast The former giant is trying to haul itself into the digital age. It's too late. The stock's been soundly trashed.
The Motley Fool August 26, 2005 W.D. Crotty	A New Stage for China Life It maintains its market share while Chinese life insurance companies grow slowly. Investors, take note.
The Motley Fool August 26, 2005 Beyers & Gardner	Don't Invest Like a Banker Bankers eschew risk and put safety over returns. Conversely, the investor manages risk by understanding the market, competitive advantage, and the opportunities for a stock they're interested in.
The Motley Fool August 26, 2005 Nathan Parmelee	Restoration Hardware: Still Under Construction The company is making improvements, the specialty retailer has yet to reward investors with a regular profit -- and there's no telling when or if it might start doing so.
The Motley Fool August 26, 2005 Stephen D. Simpson	Merck Broaches the Obvious Merck will naturally end up settling many Vioxx cases, but the details are far from clear at this point. Investors, take note.
<Older 9331-9340 Newer> Return to current articles.